Navigation Links
KPMG Optimistic About Indian Pharma’s Growt

The Indian pharma industry is well positioned to capture much of the $65 billion new business expected to open up globally next year, a new KPMG study reveals//.

"The Indian pharma industry is currently worth $6 billion - in a global industry worth $650 billion - and is growing at 10 percent, compared to the global industry rate of seven percent," said John Morris, global head of KPMG's pharmaceuticals practice, commenting on the new study.

"The generics business remains at the heart of everything India does well and so it should, considering that India accounts for 22 percent of the global generics market."

"Bearing in mind that $65 billion of prescription medicines in Europe and the US are to lose their patents in 2007-08, India is ideally positioned to sweep up much of that new business."

Morris however pointed out that opportunity now exists for India to become so much more than just a generics player and shape up as a developer of new drugs.

Much of the impetus behind India's fresh challenge for a greater share of the global industry is driven by last year's introduction of product patents.

For the previous 25 years, patents were only granted on processes - a decision which saw many MNCs abandon the subcontinent, but which resulted in India becoming a leading player in the market for generic medicines.

The expansion of India's patent system to cover products as well as processes has already started to bring the MNCs back into the fold, the report points out.

There was never much point in Indian manufacturers spending too much on research and development of their own when their new product discoveries could not be patent-protected.

With patent protection in place and foreign investors eagerly eyeing India's wealth of human resources, and its massive domestic market, significant growth opportunities abound for Indian companies.

The patent change regime in 2007-08 would open a huge international market worth $65 billion for the Indian pharma industry, the report said.

Through proactive measures such as public-private partnerships, and encouragement of research and development India could hope to capitalise on the opportunity, feels Sanjay Aggarwal, pharmaceutical sector leader for KPMG in India.

"Multinational companies that have re-entered the market since the new product patent system seek out the domestic industry's skills and infrastructures to boost their research and manufacturing activities in the subcontinent and also open up this vast, virtually untapped market," said Aggarwal.

The KPMG report quotes a leading industry figure to point out that despite recent improvements in the Indian market infrastructure, many people still "talk about India but invest in China".

Much of this is attributed to shortcomings in the current Indian regulatory environment - India still offers no data protection unlike China. There is also the issue of domestic drug pricing.

The report claims that drug prices in the Indian domestic market are the lowest in the world.

"The aims of the Indian industry - and of the government - are ambitious but will require a strong pricing environment if the Indian people are to access the life-saving and innovative medicines they need," the report states.

(Source: IANS)

Related medicine news :

1. Scientist Optimistic In Breakthrough For Causes Of Neurodegenerative Diseases
2. Doctors Optimistic on Separating the Conjoined US Twins
3. Experts Are Optimistic Of Making Waterborne Infectious Diseases A Thing Of Past
4. WHOs New Chief Very Optimistic
5. Breast Cancer Survivors Worry About Infertility
6. Breast Cancer Survivors Worry About Infertility
7. Improving Lighting Could Bring About A Change In Alzheimers Patients
8. Poll Finds Many Americans Misinformed About Cancer
9. Poll Finds Many Americans Misinformed About Cancer
10. Study Warns About The Use Of Popular Asthma Drug To Stop Childrens Coughs
11. Scientists Develop New Technology To Find About Human Ancestors’ Teet
Post Your Comments:

(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, ... Elite. The attorneys chosen by their peers for this recognition are considered among the ... Traurig Shareholders received special honors as members of this year’s Legal Elite Hall of ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... Forecast to 2022" report to their offering. ... date financial data derived from varied research sources to present ... impact on the market during the next five years, including ... sub markets, regional and country level analysis. The report provides ...
(Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
Breaking Medicine Technology: